Answering the narrow version, because the broad one does not have a single answer. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.
Asked to pay by a method with no recourse, by a supplier I had used twice before without being asked, which is what made me stop.
So the question, as narrowly as I can put it: how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
Not looking for reassurance. Looking for the part I have got wrong.
Dr.ReproEndo said:Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…
Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsEndoResFellow said:Asked to pay by a method with no recourse, by a supplier I had used twice before without being asked, which is what made me stop.
This matches mine closely enough to be worth saying so out loud. I had assumed I was the exception until I read this.
Clinical perspective, offered as context rather than as advice. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.